Medical/Pharmaceuticals
Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics
CALGARY, AB and TORONTO, May 23, 2024 /PRNewswire/ -- Providence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines and therapeutics, and the Ontario Institute for Cancer Research (OICR),Ontario's largest...
Guo Guangchang: Fosun Steadfastly Focuses on Innovation + Globalization
HONG KONG, May 23, 2024 /PRNewswire/ -- The 4th BEYOND International Technology Innovation Expo (BEYOND Expo 2024) commenced with a spectacular opening ceremony on 22 May at the Venetian Theatre in the Venetian Macao. At the opening ceremony, Guo Guangchang, Chairman of Fosun International, said ...
New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance
AMSTERDAM, May 23, 2024 /PRNewswire/ -- The race to create replacement antibiotics and antifungals to combat superbugs is falling dangerously short, putting people across the world at risk. However, a shift in research and development (R&D), including investment in access and stewardship planning...
Revolutionising Cardiac Care at Pantai Hospital Kuala Lumpur
Advanced TAVI Procedure on Patient with Severe Aortic Stenosis KUALA LUMPUR, Malaysia, May 23, 2024 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL), a leader in medical excellence and patient care, has achieved another significant medical milestone with the successful launch of its Transcath...
MediThinQ Unveils SCOPEYE 3D Micro Surgery Solution; Chris Lee of VentureBlick Assumes Chairmanship
SINGAPORE, May 23, 2024 /PRNewswire/ -- MediThinQ, the Korean startup pioneering extended reality (XR) wearable displays for surgical applications, unveils its groundbreaking SCOPEYE 3D Micro Surgery Solution. This innovative microsurgery solution leverages the latest Eyes Up Display technology t...
Bionoxx to Highlight Innovative Strategy for Addressing Immune-Related Diseases at 2024 BIO International Conference
Corporate presentation scheduled for Tuesday, 04 June 2024 at 4:00 PM PT SAN DIEGO and SEOUL, South Korea, May 23, 2024 /PRNewswire/ -- Bionoxx Inc., an innovative biotech company developing neutrophil-directed T cell modulation technology, announced today it will unveil its novel immunomodulator...
Further CYP-001 GvHD Clinical Data Published in Nature Medicine
Two-year overall survival rate in patients with steroid-resistant acute GvHD was 60% MELBOURNE, Australia, May 23, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to an...
Smartee Empowers the Next Generation of Orthodontists at the 2nd HADO Exhibition
BUDAPEST, Hungary, May 22, 2024 /PRNewswire/ -- On May 20, 2024, Smartee Denti-Technology, a global leader in clear aligners and digital orthodontic solutions, presented its innovative Smartee GS Mandibular Repositioning Technology at the 2nd HADO Exhibition, held from May 16-19, 2024 in Budapest...
Bumrungrad International Hospital Achieves GHA Accreditation with "Excellence," Demonstrating its Global Leadership Position in Medical Tourism
PALM BEACH GARDENS, Fla., May 22, 2024 /PRNewswire/ -- Bumrungrad International Hospital recently earned its third Global Healthcare Accreditation (GHA) "Accreditation with Excellence," scoring 100% across all criteria measuring the quality of care delivered to medical tourists. Bumrungrad Intern...
Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024
New report highlights innovations poised to drive significant clinical and market impact LONDON, May 22, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of theMedical Technologies to Watch in 2024 report. This ...
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016
SUZHOU, China, May 22, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I clinical study (JSKN016-101) of JSKN016, a novel bispecific antibody-drug conjugate (ADC) targeting HER3 and TROP2, in the treatment of ...
Equitable access to treatment must keep pace with latest advances in reproductive surgery
MANILA, Philippines, May 22, 2024 /PRNewswire/ -- Profound benefits of new developments in reproductive surgery that facilitate parenthood and enhance quality of life will only be fully realised by making them accessible to all people experiencing the distress of infertility. The challenge lie...
Advanced Waste Management Solution for Hospitals
SYDNEY, May 22, 2024 /PRNewswire/ -- Smart waste management in hospitals has
been increasingly important for achieving the higher standards of safety and
environmental expectation required by patients and staff compared with other
sectors.
YS Biopharma Announces Results of Extraordinary General Meeting
GAITHERSBURG, Md., May 22, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseas...
Announcement of The Shaw Laureates 2024
HONG KONG, May 21, 2024 /PRNewswire/ --
Oncology Events in Poland Solidify Collaboration with NCCN
The National Comprehensive Cancer Network participates in meetings hosted by Maria Sklodowska-Curie National Research Institute of Oncology, the Polish Oncological Society, and Alliance for Innovation to advance work adapting proven cancer treatment guidelines forPoland. WARSAW, Poland, May 21, ...
New CAS BioFinder Discovery Platform empowers drug discovery scientists to reveal insights, drive innovation, and save time
Transformative new scientific information capabilities combine an unparalleled collection of curated science data with advanced predictive models to accelerate early-stage drug discovery innovation COLUMBUS, Ohio, May 21, 2024 /PRNewswire/ -- Today, CAS, a division of the American Chemical Socie...
Etiometry Awarded Frost & Sullivan's 2024 North American Enabling Technology Leadership Award for Leading Innovation in Clinical Decision Support Systems
Etiometry's solutions provide healthcare professionals with actionable intelligence, setting new benchmarks in critical care treatment. SAN ANTONIO, May 21, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the clinical decision support for critical care industry and, based on its findin...
RemeGen Completes Patient Enrollment in Two Phase III Clinical Trials Using Telitacicept for Treatment of IgA Nephropathy and Primary Sjögren's Syndrome
YANTAI, China, May 21, 2024 /PRNewswire/ -- RemeGen Co. Ltd.
Dignitana signs an exclusivity agreement for Japan with Konica Minolta
LUND, Sweden, May 21, 2024 /PRNewswire/ -- Dignitana has signed a new multi-year Distribution Agreement for technology market leaderKonica Minolta to be the exclusive provider of The DigniCap Scalp Cooling System inJapan. DigniCap Delta is an innovative medical device used by cancer centers to m...
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00